Danske Bank A S Raises Stock Position in Astera Labs, Inc. $ALAB

Key Points

• Danske Bank boosted its stake in Astera Labs by 1,439.6%, buying an additional 49,090 shares to hold 52,500 shares worth about $8.73 million per its latest 13F filing.
• Astera Labs posted strong quarterly results, beating EPS and revenue estimates with revenue up 91.8% year‑over‑year and set Q1 guidance of $0.530–$0.540 EPS, while the stock carries a consensus "Moderate Buy" target of $199.20.
• Company insiders have been net sellers recently, disposing of a total of 1,064,888 shares (≈$150.8 million) in the last 90 days, including sales by the CEO and a director under pre‑arranged Rule 10b5‑1 plans.

Danske Bank A S increased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 1,439.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,500 shares of the company's stock after purchasing an additional 49,090 shares during the period. Danske Bank A S's holdings in Astera Labs were worth $8,734,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Perigon Wealth Management LLC raised its holdings in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company's stock worth $208,000 after purchasing an additional 73 shares during the last quarter. Clearstead Advisors LLC raised its position in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company's stock valued at $125,000 after acquiring an additional 76 shares in the last quarter. Sound Income Strategies LLC raised its position in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company's stock valued at $164,000 after acquiring an additional 76 shares in the last quarter. Venturi Wealth Management LLC raised its position in Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company's stock valued at $546,000 after acquiring an additional 84 shares in the last quarter. Finally, Great Valley Advisor Group Inc. raised its position in Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company's stock valued at $372,000 after acquiring an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Stock Down 0.7%

ALAB stock opened at $201.25 on Tuesday. The stock has a market capitalization of $34.47 billion, a P/E ratio of 164.96, a P/E/G ratio of 3.99 and a beta of 3.34. The firm has a 50-day simple moving average of $139.00 and a 200-day simple moving average of $153.00. Astera Labs, Inc. has a 52 week low of $63.40 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to analysts' expectations of $249.46 million. During the same period in the previous year, the business earned $0.37 earnings per share. The firm's revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current year.

Analyst Upgrades and Downgrades

ALAB has been the subject of several recent research reports. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Astera Labs in a research report on Tuesday, April 21st. Stifel Nicolaus set a $236.00 price objective on shares of Astera Labs in a research report on Friday. UBS Group began coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a "neutral" rating and a $180.00 price objective for the company. Finally, Weiss Ratings cut Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Monday, February 23rd. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $199.20.

Insider Transactions at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,757 shares of the company's stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.12, for a total transaction of $657,925.84. Following the completion of the sale, the director owned 67,144 shares of the company's stock, valued at approximately $11,758,257.28. This represents a 5.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of the company's stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the sale, the chief executive officer directly owned 4,069,134 shares of the company's stock, valued at approximately $713,929,560.30. This represents a 0.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,064,888 shares of company stock valued at $150,764,723 over the last ninety days. Company insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.